Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen. [electronic resource]
- The Journal of antimicrobial chemotherapy Jun 2012
- 1453-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't